Bioequivalence and Bioavailability Forum • Dabigatran EMA

Dabigatran EMA - product-specific guide [Regulatives / Guidelines]

posted by ElMaestro – Denmark, 2019-02-13 22:59 – Posting: # 19910
Views: 703

Hi nobody,

» http://www.sciencemag.org/careers/2012/02/ive-got-your-impact-factor-right-here

Thanks for this link.
"And the Journal of Negative Results in Homeopathy is the entire field of homeopathy." :-D

Best day ever.

—

 if (3) 4 



x=c("Foo", "Bar") 

b=data.frame(x) 

typeof(b[,1]) ##aha, integer?

b[,1]+1 ##then let me add 1

Best regards,
ElMaestro

“(...) targeted cancer therapies will benefit fewer than 2 percent of the cancer patients they’re aimed at. That reality is often lost on consumers, who are being fed a steady diet of winning anecdotes about miracle cures.” New York Times (ed.), June 9, 2018.

Complete thread:

Dabigatran EMA - product-specific guide nobody 2019-02-13 18:58 [Regulatives / Guidelines]
- Dabigatran EMA - product-specific guide ElMaestro 2019-02-13 22:59
  - OT: A major loss Helmut 2019-02-14 00:24
    - OT: A major loss nobody 2019-02-14 09:31
      - OT: A major loss Helmut 2019-02-14 11:37
        
        OT: A major loss nobody 2019-02-14 13:40
- Dabigatran EMA - product-specific guide Helmut 2019-02-14 12:12
  - Dabigatran EMA - product-specific guide nobody 2019-02-14 13:34
    - Dabigatran EMA - product-specific guide Helmut 2019-02-14 13:52
      - Dabigatran EMA - product-specific guide nobody 2019-02-14 15:01